Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The authors and administrators reserve the right to modify, add, or remove content without notification
All dosing is prescriber-determined
However, newer medications target multiple metabolic hormones: GLP-1 drugs (single-hormone): semaglutide medications like Wegovy and Ozempic Dual-agonist drugs: tirzepatide medications like Mounjaro and Zepbound (target GLP-1 and GIP receptors) Triple-agonist drugs: retatrutide (targets GLP-1, GIP and glucagon receptors) Researchers believe stimulating multiple hormone pathways may produce stronger effects on appetite, metabolism and energy expenditure
Weight Loss: They slow down the rate at which the stomach empties, making a person feel full for longer
Cork, PhD , study co-author, physiologist, and senior lecturer in the School of Medicine at Anglia Ruskin University
